InvestorsHub Logo
Followers 39
Posts 3916
Boards Moderated 0
Alias Born 08/15/2009

Re: someconcerns post# 56

Wednesday, 05/03/2017 5:17:33 PM

Wednesday, May 03, 2017 5:17:33 PM

Post# of 289
http://savarapharma.com/development/pipeline/

A Phase 2/3 clinical trial of Molgradex to treat patients with PAP is currently on-going in the EU and Japan; top-line results are anticipated in the first half of 2018.

Savara anticipates initiating a pivotal Phase 3 clinical trial of AeroVanc for the treatment of MRSA in cystic fibrosis patients in second half of 2017.

Aironite is currently in clinical studies for the treatment of heart failure with preserved ejection fraction (HFpEF).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SVRA News